Erratum to: Diabetes Ther (2014) 5:141–153 DOI 10.1007/s13300-014-0055-1
The authors of the above mentioned manuscript would like to make the following clarification. The associated ClinicalTrials.gov registration number for this GlaxoSmithKline trial “Albiglutide Thorough ECG Study in Healthy Volunteers” was inadvertently omitted within the previously published results. The full registration number for this trial is NCT01406262.
Open Access
This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found under doi:10.1007/s13300-014-0055-1.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Darpo, B., Zhou, M., Matthews, J. et al. Erratum to: Albiglutide Does Not Prolong QTc Interval in Healthy Subjects: A Thorough ECG Study. Diabetes Ther 5, 609 (2014). https://doi.org/10.1007/s13300-014-0074-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13300-014-0074-y